---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-000296"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2024-01-02T23:59:59+00:00"
generated_at: "2026-06-07T05:28:59.735721+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pasithea shareholders approve classified board, supermajority vote, eliminate written consent

## Summary
- Stockholders approved classifying Board into three classes with staggered 3-year terms; removal only for cause.
- Approved elimination of stockholder ability to act by written consent and to call special meetings.
- Approved requirement of 66 2/3% vote to amend Bylaws; vote results: 10,473,072 for, 1,513,065 against.
- Certificate restated to include officer exculpation and other governance changes; effective Dec 29, 2023.
- Clerical filing corrected reverse stock split (1:20) to be an amendment to the Restated Certificate.

## SEC filing metadata
- accession: 0001213900-24-000296
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2024-01-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/0001213900-24-000296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/ea190803-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-000296
- JSON: https://secwatch.observer/filing/0001213900-24-000296.json
- Plain text: https://secwatch.observer/filing/0001213900-24-000296.txt

## Key facts
- Governance Changes
  Pasithea Therapeutics Corp.: Amended and restated bylaws to be consistent with charter changes and to add exclusive forum provision and adjust notice periods for stockholder proposals (effective 2023-12-29).
  - Change: bylaw amendment
  - Effective: 2023-12-29
  source text: The Board had previously approved an amendment and restatement of the Bylaws (as so amended and restated, the “Restated Bylaws”), to be effective upon the Effective Time, to be consistent with any changes to the Certificate adopted and approved by the Company’s stockholders at the Reconvened Meeting
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/0001213900-24-000296-index.htm
- Governance Changes
  Pasithea Therapeutics Corp.: Amended and restated certificate of incorporation to include changes approved by stockholders, such as classified board, removal of stockholder ability to call special meetings, elimination of stockholder action by written consent, and supermajority vote for bylaw amendments (effective 2023-12-29).
  - Change: charter amendment
  - Effective: 2023-12-29
  source text: on December 29, 2023, following the Reconvened Meeting, the Company filed the Restated Certificate with the Secretary of State of the State of Delaware implementing the approved changes and the Restated Certificate was effective immediately upon filing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/0001213900-24-000296-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.